{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T13:13:06Z","timestamp":1783084386438,"version":"3.54.6"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.amjms.2020.05.005","type":"journal-article","created":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T23:52:59Z","timestamp":1589154779000},"page":"261-267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Teneligliptin, a DPP-4 Inhibitor, Decreases Plasma Levels of Inflammatory Chemokines During a Standard Meal Test in Patients With Type 2 Diabetes"],"prefix":"10.1016","volume":"360","author":[{"given":"Yoshimasa","family":"Aso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Kase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Sagara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshie","family":"Iijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Tomaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruo","family":"Jojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Usui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjms.2020.05.005_bib0001","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/B978-0-12-385855-9.00003-5","article-title":"Dipeptidyl peptidase in autoimmune pathophysiology","volume":"53","author":"Ohnuma","year":"2011","journal-title":"Adv Clin Chem"},{"key":"10.1016\/j.amjms.2020.05.005_bib0002","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/713609354","article-title":"Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV","volume":"40","author":"Lambeir","year":"2003","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.amjms.2020.05.005_bib0003","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.trsl.2011.09.005","article-title":"Serum level of soluble CD26\/dipeptidyl peptidase-4 (DPP-4) predicts the response to sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes controlled inadequately by metformin and\/or sulfonylurea","volume":"159","author":"Aso","year":"2012","journal-title":"Transl Res"},{"key":"10.1016\/j.amjms.2020.05.005_bib0004","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1189\/jlb.3MR0915-401R","article-title":"CD26\/dipeptidylpeptidase IV-chemokine interactions: double-edged regulation of inflammation and tumor biology","volume":"99","author":"Mortier","year":"2016","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.amjms.2020.05.005_bib0005","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/bjd.14601","article-title":"Gautier S; French Association of Regional PharmacoVigilance Centres. Bullous pemphigoid and dipeptidyl peptidase IV inhibitors: a case-noncase study in the French Pharmacovigilance Database","volume":"175","author":"B\u00e9n\u00e9","year":"2016","journal-title":". Br J Dermatol"},{"key":"10.1016\/j.amjms.2020.05.005_bib0006","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1001\/jamadermatol.2018.2352","article-title":"Association of bullous pemphigoid with dipeptidyl-peptidase 4 inhibitors in patients with diabetes: estimating the risk of the new agents and characterizing the patients","volume":"154","author":"Kridin","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.amjms.2020.05.005_bib0007","unstructured":"Shinohara K, Iijima T, Jojima T, et al. Three cases of bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitor therapy showing unfavorable outcomes despite immediate discontinuation of medication. Clin Case Rep, in press."},{"key":"10.1016\/j.amjms.2020.05.005_bib0008","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1365-2133.2006.07601.x","article-title":"Serum chemokine profile in patients with bullous pemphigoid","volume":"156","author":"Nakashima","year":"2007","journal-title":"Br J Dermatol"},{"issue":"9863","key":"10.1016\/j.amjms.2020.05.005_bib0009","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.amjms.2020.05.005_bib0010","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.4049\/jimmunol.181.2.1120","article-title":"Inhibition of CD26\/dipeptidyl peptidase IV enhances CCL11\/eotaxin-mediated recruitment of eosinophils in vivo","volume":"181","author":"Forssmann","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.amjms.2020.05.005_bib0011","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1365-2133.2003.05066.x","article-title":"High level of thymus and activation-regulated chemokine in blister fluid and sera of patients with bullous pemphigoid","volume":"148","author":"Kakinuma","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.amjms.2020.05.005_bib0012","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.diabres.2013.12.047","article-title":"Effect of a mixed meal on plasma lipids, insulin resistance and systemic inflammation in non-obese Indian adults with normal glucose tolerance and treatment na\u00efve type-2 diabetes","volume":"104","author":"Meher","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.amjms.2020.05.005_bib0013","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.diabres.2012.01.005","article-title":"Effect of glucose ingestion in plasma markers of inflammation and oxidative stress: analysis of 16 plasma markers from oral glucose tolerance test samples of normal and diabetic patients","volume":"99","author":"Choi","year":"2013","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.amjms.2020.05.005_bib0014","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fimmu.2015.00084","article-title":"Eotaxin-1 (CCL11)","volume":"6","author":"Williams","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.amjms.2020.05.005_bib0015","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1046\/j.1365-2133.2000.03599.x","article-title":"Elevated levels of eotaxin and interleukin-5 in blister fluid of bullous pemphigoid: correlation with tissue eosinophilia","volume":"143","author":"Wakugawa","year":"2000","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.amjms.2020.05.005_bib0016","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.diabres.2015.10.012","article-title":"Sitagliptin, a DPP-4 inhibitor, alters the subsets of circulating CD4+ T cells in patients with type 2 diabetes","volume":"110","author":"Aso","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"issue":"7362","key":"10.1016\/j.amjms.2020.05.005_bib0017","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nature10357","article-title":"The ageing systemic milieu negatively regulates neurogenesis and cognitive function","volume":"477","author":"Villeda","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.amjms.2020.05.005_bib0018","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s12020-015-0688-5","article-title":"Sitagliptin, a dipeptidyl peptidase-4 inhibitor, increases the number of circulating CD34\u207aCXCR4\u207a cells in patients with type 2 diabetes","volume":"50","author":"Aso","year":"2015","journal-title":"Endocrine"},{"key":"10.1016\/j.amjms.2020.05.005_bib0019","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.autrev.2013.10.010","article-title":"Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases","volume":"13","author":"Antonelli","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.amjms.2020.05.005_bib0020","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1365-2133.2003.05066.x","article-title":"High level of thymus and activation-regulated chemokine in blister fluid and sera of patients with bullous pemphigoid","volume":"148","author":"Kakinuma","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.amjms.2020.05.005_bib0021","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1172\/JCI3335","article-title":"Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls","volume":"102","author":"B\u00fcdinger","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.amjms.2020.05.005_bib0022","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s00403-006-0661-5","article-title":"Both Th1 and Th2 chemokines are elevated in sera of patients with autoimmune blistering diseases","volume":"298","author":"Echigo","year":"2006","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.amjms.2020.05.005_bib0023","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.2337\/dc10-0187","article-title":"The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha","volume":"33","author":"Fadini","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjms.2020.05.005_bib0024","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/jdi.12572","article-title":"Vildagliptin reduces plasma stromal cell-derived factor-1\u03b1 in patients with type 2 diabetes compared with glimepiride","volume":"8","author":"Park","year":"2017","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.amjms.2020.05.005_bib0025","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1189\/jlb.3MR0915-401R","article-title":"CD26\/dipeptidylpeptidase IV-chemokine interactions: double-edged regulation of inflammation and tumor biology","volume":"99","author":"Mortier","year":"2016","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.amjms.2020.05.005_bib0026","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.2337\/diabetes.54.10.2988","article-title":"Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: potential importance of selectivity over dipeptidyl peptidases 8 and 9","volume":"54","author":"Lankas","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.amjms.2020.05.005_bib0027","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1016\/j.bmc.2012.08.012","volume":"20","author":"Yoshida","year":"2012","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.amjms.2020.05.005_bib0028","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2337\/dc17-1827","article-title":"Precision Medicine in Type 2 Diabetes: Clinical Markers of Insulin Resistance Are Associated With Altered Short- and Long-term Glycemic Response to DPP-4 Inhibitor Therapy","volume":"41","author":"Dennis","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjms.2020.05.005_bib0029","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejim.2015.11.026","article-title":"Uric acid in metabolic syndrome: From an innocent bystander to a central player","volume":"29","author":"Kanbay","year":"2016","journal-title":"Eur J Intern Med"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962920301786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962920301786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:37:56Z","timestamp":1757702276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962920301786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0002962920301786"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2020.05.005","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Teneligliptin, a DPP-4 Inhibitor, Decreases Plasma Levels of Inflammatory Chemokines During a Standard Meal Test in Patients With Type 2 Diabetes","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2020.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}